Skip to content

Clinical trials

Completed Phase 1 Lymphoma, Mantle-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 1 Status: Completed Clear all

219 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200012
20016
200214
20038
200412
20055
20069
200715
20086
20099
20109
201110
20126
20135
20147
20154
20168
20178
20188
20194
20204
20213
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed219

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)49
Memorial Sloan Kettering Cancer Center11
National Institutes of Health Clinical Center (CC)9
M.D. Anderson Cancer Center6
Case Comprehensive Cancer Center5
Fred Hutchinson Cancer Center5
Mayo Clinic5
Northwestern University5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
City of Hope Medical Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell219
Lymphoma, Follicular181
Lymphoma, Large B-Cell, Diffuse171
Leukemia, Lymphocytic, Chronic, B-Cell164
Lymphoma, B-Cell, Marginal Zone160
Lymphoma, Non-Hodgkin149
Burkitt Lymphoma140
Precursor Cell Lymphoblastic Leukemia-Lymphoma131
Lymphoma, Large-Cell, Immunoblastic123
Lymphoma112

Trials

Showing 1 to 25 of 219. Each trial links to its page on Pharma Observatory.

119 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.